The Johnson & Johnson (NYSE:JNJ) is going up by 0.01% in today’s trading session, a rise equivalent to 0.01% of the stock’s price from yesterday’s market close. A news came out on 08/21/19 stating that Thinking about trading options or stock in Walt Disney Co, Johnson & Johnson, Netflix, Target, or Walmart? by WSJ. The lowest point that the shares touched during the trading session was $130.85, while the peak of the day was recorded at a share price of $132.41. JNJ finished the previous session at $131.53 according to the data provided by Barchart, while the trading volume was observed to be $2,229,982.
In the 100 days of trading, JNJ managed to top a 136.47% Moving average. Additionally, Johnson & Johnson shares have achieved a 52-week range between 121.00 and 148.99 alongside 100 days raw stochastic set at 20.13%.
The number of shares outstanding, according to the fundamentals of the company, is set at 2.65B, equal to the value of $348.88B in market capitalization. Financial analysts indicate that JNJ shares should be still ranked as a “Outperform”. In the last 30 days, Johnson & Johnson shares went down by -2.10%, adding 134.10 to growth in value, on top of a +2.45% boost since 07/22/19.
Johnson & Johnson (NYSE:JNJ) Analyst’s Estimates
Johnson & Johnson (JNJ) could record at least $2.01 per share in quarterly earnings in the upcoming report on 10/15/2019, a number that would actually represent an increase of 6.15% YOY.
According to the average analyst rating, Johnson & Johnson would be rated as 2.28. Out of 18 different analysts monitoring JNJ stock, 5 analysts rate the stock as a BUY, 7 suggest to give the rating of HOLD, 5 indicate that JNJ is an OUTPERFORM, 1 rated the stock as a SELL, and 0 analyst believes that the stock should be rated as UNDERPERFORM.
On Jul-12-19, the stock earned a Resumed rating due to a new analyst call from Credit Suisse, while analysts from Goldman believe that the stock is set at Buy, as concluded on May-28-19. Barclays, is still rather wary about the stock, deciding to keep the rating at Equal Weight as confirmed through a call on Jan-23-19.
Bernstein, on the other hand, provided a rather enthusiastic opinion on the rating, concluded in an analyst call on Jun-27-18, giving the stock a Mkt Perform rating.
JNJ Key Ratios To Watch:
Taking in account the profitability of the Company, gross profit margin of +66.66% has been attained, while the operating margin has been recorded at +26.07%. The firm is also showcasing profitability through returns on assets in the company’s ownership, with ROA set at 9.86%. Beta value of the stock is recorded at 0.66. Additionally, Johnson & Johnson is recording price volatility of 1.14% for the period of the last seven days and 1.35% in the last 30 days.
Johnson & Johnson (NYSE:JNJ) Technical Outlook
For the period of the last 50 days, Johnson & Johnson had its Raw Stochastic average set at 20.13% for the latest technical analysis. In comparison to the period of the last 20 days, the present Raw Stochastic average for the last 50 days poses as improvement, set at 52.45%. Stochastic %K for Johnson & Johnson, with the last 20 days included, was set at 49.92%, having Stochastic %D topping 53.53%. Based on the previous performance of the company for the mentioned period, there are more than several recorded moving trends. When it comes to the period of the last 12 months, accounting the time for year-to-date, price performance appears to be discouraging for Johnson & Johnson stocks with recording -3.91% in metrics.
Johnson & Johnson Insider Watch:
As far as the position of shares issued by Johnson & Johnson (NYSE:JNJ) for the period concluded at the market close of 08/21/19, 1,220 institutional investors increased their positions in JNJ shares by 201,369,194, 1,379 decreased positions by 56,273,920 and 245 institutional investors decided to hold positions at 1,694,390,150. These numbers put the complete list of institutional holdings set at 1,952,033,264 shares, in accordance with filings submitted to the Securities and Exchange Commission. The stock had another 95 institutional investments with 2,223,084 new shares in addition to having 77 institutional investors selling their positions in 5,580,944 shares.